Kelley B. Mowatt

Statistics

Publications

Citations

329

H-Index

Active since

2013

Affiliations

Columbia University Irving Medical Center(Current)

Kelley B. Mowatt is an author at Columbia University Irving Medical Center specializing in pharmacology, neuroendocrine tumor pharmacotherapy, and capecitabine-based therapy.

ORCID

Publications per year

2013–2014

Publications

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz et al. · Cancer Chemotherapy and Pharmacology · 2013 · 257 citations

Medicine, Oncology, Pharmacology +16

Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.

Robert L. Fine, Anthony P. Gulati, Dawn Tsushima et al. · Journal of Clinical Oncology · 2014 · 72 citations

Medicine, Oncology, Pharmacology +14

1–2 of 2